首页|靶向血管内皮糖萼的抗休克药物

靶向血管内皮糖萼的抗休克药物

扫码查看
内皮糖萼(endothelial glycocalyx,EG)是位于血管内皮腔内侧的1层带负电荷的绒毛状结构,为一种由多糖分子与蛋白质结合而成的复合物.血管EG作为休克期间保护血管内皮的重要屏障,可发挥调节血管张力、调控细胞信号转导、维持血管完整性、调节炎症及凝血障碍等重要生理功能,从而维持机体血管内稳态.休克发生时EG的结构破坏、脱落是微循环障碍的主要原因之一.靶向EG的抗休克药物主要通过抑制EG降解酶、炎症因子的表达等途径减少EG组分的脱落,维持内皮结构完整性,改善微血管通透性来治疗休克.深入探究血管EG的具体损伤机制及其治疗靶点,可为靶向EG的药物探索和休克的临床治疗提供理论依据和治疗参考.
Antishock drugs targeting vascular endothelial glycocalyx
Endothelial glycocalyx(EG)is a layer of negatively charged villus-like structure located on the inner side of the endothelial lumen of blood vessels,which is a complex of polysaccharide molecules bound to proteins.As an important barrier protecting the vascular endothelium during shock,vascular EG plays important physiological functions such as regulating vascular tone,modulating cell signal transduction,maintaining vascular integrity,and regulating inflammation and coagulation disorders,thereby maintaining intravascular homeostasis in the body.The structural destruction and shedding of EG during the onset of shock is one of the primary causes of microcirculatory disorders.Antishock drugs targeting EG mainly reduce the shedding of EG components,maintain endothelial structural integrity,and improve microvascular permeability to treat shock by inhibiting the expression of EG-degrading enzymes and inflammatory factors.In-depth exploration of the specific injury mechanisms of vascular EG injury and its therapeutic targets can provide theoretical basis and therapeutic references for drug exploration targeting EG and clinical treatment of shock.

shockvascular endotheliumendothelial glycocalyx

曾滨、鲁晓红、姚立农

展开 >

陕西中医药大学第二临床医学院临床医学系,陕西 咸阳 712046

空军军医大学唐都医院重症医学科,西安 710038

陕西中医药大学附属医院麻醉科,陕西 咸阳 712000

休克 血管内皮 内皮糖萼

空军军医大学唐都医院学科创新发展计划

2021JSZH-004

2024

临床与病理杂志
中南大学

临床与病理杂志

CSTPCD
影响因子:0.559
ISSN:1673-2588
年,卷(期):2024.44(1)
  • 36